Swedish Orphan Biovitrum AB (publ) (STO:SOBI)
Sweden flag Sweden · Delayed Price · Currency is SEK
299.00
+2.40 (0.81%)
May 6, 2025, 5:16 PM CET

STO:SOBI Revenue

Swedish Orphan Biovitrum AB had revenue of 6.47B SEK in the quarter ending March 31, 2025, with 3.34% growth. This brings the company's revenue in the last twelve months to 26.24B, up 13.38% year-over-year. In the year 2024, Swedish Orphan Biovitrum AB had annual revenue of 26.03B with 17.65% growth.

Revenue (ttm)
26.24B
Revenue Growth
+13.38%
P/S Ratio
3.88
Revenue / Employee
13.84M
Employees
1,806
Market Cap
101.87B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202426.03B3.90B17.65%
Dec 31, 202322.12B3.33B17.74%
Dec 31, 202218.79B3.26B21.00%
Dec 31, 202115.53B268.00M1.76%
Dec 31, 202015.26B1.01B7.11%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sectra AB 3.30B
Getinge AB 35.57B
Camurus AB 1.87B
Medicover AB 23.56B
AddLife AB 10.42B
Vitrolife AB 3.61B
Bonesupport Holding AB 997.85M
Vimian Group AB 4.24B
Revenue Rankings